UBS: Fast Take: FEMSA "SCJN rules in favor of FEMSA, upholding the..."

Research evidence excerpt

UBS: Fast Take: FEMSA "SCJN rules in favor of FEMSA, upholding the..."

by SEBI, and certification from NISM in no way

guarantee performance of the intermediary or provide any assurance of returns to investors. UBS may have debt holdings or positions in the subject Indian

company/companies. UBS may have financial interests (e.g. loan/derivative products, rights to or interests in investments, etc.) in the subject Indian

company / companies from time to time. Within the past 12 months, UBS may have received compensation for non-investment banking securities-related

services and/or non-securities services from the subject Indian company/companies. The subject company/companies may have been a client/clients of

UBS during the 12 months preceding the date of distribution of the research report with respect to investment banking and/or non-investment banking

securities-related services and/or non-securities services. With regard to information on associates, please refer to the Annual Report at: https://

www.ubs.com/global/en/about_ubs/investor_relations/annualreporting.html The Research Annual Compliance Report for UBS Securities India Private

Limited is available on www.ubs.com/ubssi under Research tab. Taiwan: Except as otherwise specified herein, this material may not be distributed in

Taiwan. Information and material on securities/instruments that are traded in a Taiwan organized exchange is deemed to be issued and distributed by

UBS Securities Pte. LTD., Taipei Branch, which is licensed and regulated by Taiwan Financial Supervisory Commission. Save for securities/instruments that

are traded in a Taiwan organized exchange, this material should not constitute "recommendation" to clients or recipients in Taiwan for the covered